Joint Venture (JV)

Joint Venture (JV) refers to a strategic partnership where two or more companies create a shared entity or agreement to pursue defined business goals, often involving shared investment, risk, and operational control. In life sciences, joint ventures may focus on manufacturing capacity expansion, regional commercialisation, or platform development. JVs allow participants to combine complementary strengths while accelerating execution in competitive markets.

The biopharmaceutical industry uses joint ventures to scale manufacturing, enter new geographies, and share costs for capital-intensive operations. Biologics production facilities, vaccine manufacturing, and cell therapy supply chains often require partnerships due to complexity and cost. JV structures define governance, intellectual property ownership, revenue sharing, and exit mechanisms through detailed contractual arrangements. Regulatory and compliance responsibilities must be clearly allocated to maintain quality standards and oversight across both partners. As global biomanufacturing demand increases and novel therapeutic modalities require specialised capabilities, joint ventures remain important growth mechanisms enabling companies to access expertise and capacity beyond their individual resources.